Amid a massive restructuring effort and following some setbacks in court, Bayer’s proposed animal health sale has churned up some interest.
Private equity groups are shopping the unit, which could fetch up to €8 billion in needed cash for the German conglomerate, the Financial Times reports.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,